Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ENANTA PHARMACEUTICALS, INC (ENTA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ENANTA PHARMACEUTICALS, INC (ENTA), most recent 12 months reported: revenue $65.26M, net loss $63.23M, free cash flow -$36.94M. Latest balance sheet on file: liquid cash $189.51M. From SEC filings. Others in Pharmaceutical Preparations: Journey Medical Corp · CYTOKINETICS, INCORPORATED · AbCellera Biologics Inc. · WAVE LIFE SCIENCES, INC. · Bicycle Therapeutics plc · AYTU BIOPHARMA, INC. · Nektar Therapeutics · PROTHENA CORPORATION PUBLIC LIMITED COMPANY

Stock screener

Watchlist